Overexpression of CD73 in prostate cancer is associated with lymph node metastasis

Pathology and Oncology Research

Volumn 19, Issue 4, 2013, Pages 811-814

  Yang, Qing ^a   Du, Jun ^a   Zu, Lingling ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

CD73; Immunohistochemistry; Lymph node; Metastasis; Prostate cancer

Indexed keywords

5' NUCLEOTIDASE;

ADULT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

5'-NUCLEOTIDASE; CHI-SQUARE DISTRIBUTION; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 84885140969     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9648-7     Document Type: Article

References (23)

1. Ruan Y, Yu W, Cheng F et al (2012) Detection of prostate stem cell antigen expression in human prostate cancer using quantum-dot-based technology. Sensors (Basel) 12(5):5461-5470
2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60(5):277-300
3. Liu Z, Ren G, Shangguan C et al (2012) ATRA inhibits the proliferation of DU145 prostate cancer cells through reducing the methylation level of HOXB13 gene. PLoS One 7(7):e40943
4. Resta R, Yamashita Y, Thompson LF (1998) Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 161:95-109
5. Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5′-nucleotidase (CD73). Purinergic Signal 2(2):351-360
6. Zhang B (2010) CD73: a novel target for cancer immunotherapy. Cancer Res 70(16):6407-6411
7. Niemela J, Henttinen T, Yegutkin GG et al (2004) IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-50-nucleotidase) upregulation. J Immunol 172(3):1646-1653
8. Jin D, Fan J, Wang L et al (2010) CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res 70(6):2245-2255
9. Leth-Larsen R, Lund R, Hansen HV et al (2009) Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Mol Cell Proteomics 8(6):1436-1439
10. Strohmeier GR, Lencer WI, Patapoff TW et al (1997) Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J Clin Invest 99(11):2588-2601
11. Lennon PF, Taylor CT, Stahl GL, Colgan SP (1998) Neutrophil-derived 50-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 188(8):1433-1443
12. Spychala J (2000) Tumor-promoting functions of adenosine. Pharmacol Ther 87(2-3):161-173
13. Canbolat O, Durak I, Cetin R et al (1996) Activities of adenosine deaminase, 59-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Res Treat 37(2):189-193
14. Wang L, Zhou X, Zhou T et al (2008) Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J Cancer Res Clin Oncol 134(3):365-372
15. Yegutkin GG, Marttila-Ichihara F, Karikoski M et al (2011) Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. Eur J Immunol 41(5):1231-1241
16. Wu XR, He XS, Chen YF et al (2012) High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. J Surg Oncol 106(2):130-137
17. Liu N, Fang XD, Vadis Q (2012) CD73 as a novel prognostic biomarker for human colorectal cancer. J Surg Oncol 106(7):918-919
18. Cappellari AR, Vasques GJ, Bavaresco L et al (2012) Involvement of ecto-5′-nucleotidase/CD73 in U138MG glioma cell adhesion. Mol Cell Biochem 359(1-2):315-322
19. Kondo T, Nakazawa T, Murata SI, Katoh R (2006) Expression of CD73 and its ecto-5′-nucleotidase activity are elevated in papillary thyroid carcinomas. Histopathology 48(5):612-614
20. Wang L, Fan J, Thompson LF et al (2011) CD73 has distinct roles in non hematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest 121(6):2371-2382
21. Stagg J, Divisekera U, Duret H et al (2011) CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res 71(8):2892-2900
22. Stagg J, Divisekera U, McLaughlin N et al (2010) Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci USA 107(4):1547-1552
23. Lee H, Lin EC, Liu L, Smith JW (2003) Gene expression profiling of tumor xenografts: in vivo analysis of organ-specific metastasis. Int J Cancer 107(4):528-534